Celldex Therapeutics | CLDX - Market Capitalization

Stock Price
33.20
Daily Change
0.79 2.44%
Monthly
6.58%
Yearly
108.28%
Q2 Forecast
30.13

Celldex Therapeutics reported $2.2B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 107M 16M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Northwest Biotherapeutics USD 246M 110M Apr/2026
Pfizer USD 141.57B 6.48B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025